|
Market Closed -
Nasdaq
23:00:00 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 240.74 USD | -1.27% |
|
-2.06% | +41.61% |
| 09-16 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 09-16 | Jazz Pharmaceuticals plc Presents at Deutsche Bank 2026 Healthcare Summit, Sep-16-2026 08:00 AM |
| Market Cap | 15.63B 13.61B 12.85B 11.67B 21.87B 1,498B 21.94B 154B 59.35B 762B 58.7B 57.4B 2,453B | P/E 2026 * |
16.5x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 17.3B 15.07B 14.23B 12.92B 24.21B 1,659B 24.3B 170B 65.71B 844B 65B 63.55B 2,716B | EV / Sales 2026 * |
3.66x | EV / Sales 2027 * | 3.07x |
| Free-Float |
96.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
CBOE
| JAZZ | Real-time | |
|
Xetra
| J7Z | Delayed | |
|
Tradegate
| J7Z | Real-time | |
|
Boerse Muenchen
| J7Z | Real-time | |
|
Deutsche Boerse AG
| J7Z | Delayed | |
|
Börse Stuttgart
| J7Z | Delayed | |
|
Berne S.E.
| J7Z | End-of-day quote | |
|
Borsa Italiana
| 1JAZZ | End-of-day quote |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | -1.27% | ||
| 1 week | -2.06% | ||
| Current month | -3.97% | ||
| 1 month | -3.20% | ||
| 3 months | +7.16% | ||
| 6 months | +33.29% | ||
| Current year | +41.61% |
| 1 week | 238.98 |  | 247.31 |
| 1 month | 236 | | 266.38 |
| Current year | 156.95 | | 266.38 |
| 1 year | 125.78 | | 266.38 |
| 3 years | 95.49 | | 266.38 |
| 5 years | 95.49 | | 266.38 |
| 10 years | 86.88 | | 266.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 11/08/2025 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 01/03/2024 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 01/03/2003 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 18/01/2012 |
Rick Winningham
BRD | Director/Board Member | 66 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 A | Sell | General Counsel | -1,200 | 0.0018% | ||
| 9/8/26 A | Tax | Chief Executive Officer | -3,967 | 0.0061% | ||
| 9/8/26 A | Tax | Chief Technology Officer | -1,427 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | -2.06% | +87.64% | +80.02% | 15.63B | |
| +0.04% | +3.34% | +53.32% | +102.40% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +65.73% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.84% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +42.07% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +97.98% | 186B | |
| Average | -0.10% | +2.72% | +31.49% | +48.52% | 361.74B | |
| Weighted average by Cap. | -0.04% | +3.07% | +35.07% | +61.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.72B 4.11B 3.88B 3.53B 6.61B 453B 6.63B 46.4B 17.93B 230B 17.74B 17.34B 741B | 5.01B 4.36B 4.12B 3.74B 7.01B 480B 7.03B 49.2B 19.01B 244B 18.81B 18.39B 786B |
| Net income | 1B 875M 826M 751M 1.41B 96.33B 1.41B 9.87B 3.82B 49.01B 3.77B 3.69B 158B | 1.14B 995M 939M 853M 1.6B 109B 1.6B 11.22B 4.34B 55.68B 4.29B 4.19B 179B |
| Net Debt | 1.68B 1.46B 1.38B 1.25B 2.35B 161B 2.35B 16.47B 6.37B 81.77B 6.3B 6.16B 263B | -277M -242M -228M -207M -388M -26.6B -390M -2.73B -1.05B -13.53B -1.04B -1.02B -43.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | $240.74 | -1.27% | 2,214,759 |
| 17/09/26 | $243.84 | +0.10% | 569,597 |
| 16/09/26 | $243.59 | +1.15% | 602,267 |
| 15/09/26 | $240.83 | -2.05% | 702,583 |
| 14/09/26 | $245.87 | +0.03% | 465,464 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
